Related Experiment Video

Updated: Oct 11, 2025

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

310

Increased odds ratio for erectile dysfunction in COVID-19 patients

J Katz1, S Yue2, W Xue2

  • 1Department of Oral and Diagnostic Sciences, University of Florida College of Dentistry, POB 100414-0414, Gainesville, FL, 32610, USA. jkatz@dental.ufl.edu.

Journal of Endocrinological Investigation
|November 30, 2021
PubMed

Insights

COVID-19 patients show a significantly higher likelihood of developing erectile dysfunction, even after accounting for common risk factors and demographics. This study highlights a strong association between the two conditions.

Area of Science:

  • Medical research
  • Epidemiology
  • Urology

Background:

  • Erectile dysfunction (ED) and COVID-19 share common risk factors such as vascular issues, inflammation, cardiovascular disease, diabetes, and obesity.
  • Understanding the potential link between these conditions is crucial for comprehensive patient care.

Purpose of the Study:

  • To investigate the association between erectile dysfunction and a history of COVID-19 infection.
  • To determine if COVID-19 independently increases the risk of erectile dysfunction.

Main Methods:

  • Utilized a patient registry platform (i2b2) to access de-identified health records.
  • Employed logistic regression analysis on ICD-10 diagnosis codes to calculate odds ratios.
  • Adjusted for various demographic and comorbidity factors including age, smoking status, race, respiratory disease, obesity, circulatory disease, and diabetes.

Main Results:

  • Patients with a history of COVID-19 were 3.3 times more likely to have erectile dysfunction.
  • The association remained significant after adjusting for age (OR 4.8), smoking status (OR 3.5), and race (OR 2.6).
  • Adjusting for comorbidities showed increased odds ratios for erectile dysfunction in COVID-19 patients: 1.6 (respiratory disease), 1.8 (obesity), 1.9 (circulatory disease), and 2.3 (diabetes).

Conclusions:

  • A strong association exists between COVID-19 and erectile dysfunction.
  • This link persists even after controlling for known risk factors and demographic variables.
  • Further research may be warranted to elucidate the underlying mechanisms connecting COVID-19 and erectile dysfunction.
Abstract

Keywords:
COVID-19Endothelial disruptionErectile dysfunctionOdds ratio

More Related Videos

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-1906:29

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19

Published on: May 25, 2022

2.5K
Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

3.5K

Related Concept Videos

Odds Ratio01:09

Odds Ratio

The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
365
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
2.1K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.7K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
21
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
272
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
106